LBO — ASCENSION CALUMET HOSPITAL
IRR: 21.9% | MOIC: 2.69x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
21.9%
IRR
2.69x
MOIC
$17.2M
Entry EV
$31.7M
Exit EV
$8.9M
Equity Invested
Sources & Uses
S&UTotal · $17.2M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $6.7M | 38.8% | |
| Sub Debt | $1.7M | 9.7% | |
| Equity | $8.9M | 51.5% | |
| Enterprise Value | $16.7M | 97.1% | |
| Transaction Fees | $0.5M | 2.9% | |
| Total Uses | $17.2M | 100.0% |
Interpretation
INTAt 2.69x MOIC and 21.9% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $3.0M |
| Exit Ev | $31.7M |
| Net Debt At Exit | $7.9M |
| Equity At Exit | $23.9M |
| Equity Invested | $8.9M |
| Total Value Created | $15.0M |
| Value From Growth | $14.2M |
| Value From Multiple | $0.8M |
| Value From Deleveraging | $0.5M |